title: AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.
abstract: Complete arginase I deficiency is the least severe urea cycle disorder, characterized by hyperargininemia and infrequent episodes of hyperammonemia. Patients suffer from neurological impairment with cortical and pyramidal tract deterioration, spasticity, loss of ambulation and seizures, and is associated with intellectual disability. In mice, onset is heralded by weight loss beginning around day 15; gait instability follows progressing to inability to stand and development of tail tremor with seizure-like activity and death. Here we report that hyperargininemic mice treated neonatally with an adeno-associated virus (AAV)-expressing arginase and followed long-term lack any presentation consistent with brain dysfunction. Behavioral and histopathological evaluation demonstrated that treated mice are indistinguishable from littermates, and that putative compounds associated with neurotoxicity are diminished. In addition, treatment results in near complete resolution of metabolic abnormalities early in life; however, there is the development of some derangement later with decline in transgene expression. Ammonium challenging revealed that treated mice are affected by exogenous loading much greater than littermates. These results demonstrate that AAV-based therapy for hyperargininemia is effective and prevents development of neurological abnormalities and cognitive dysfunction in a mouse model of hyperargininemia; however, nitrogen challenging reveals that these mice remain impaired in the handling of waste nitrogen.
authors: Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA 90095-7054, USA.
authors: E K
authors: EK
authors: Lee
authors: C
authors: C
authors: Hu
authors: R
authors: R
authors: Bhargava
authors: R
authors: R
authors: Ponnusamy
authors: H
authors: H
authors: Park
authors: S
authors: S
authors: Novicoff
authors: N
authors: N
authors: Rozengurt
authors: B
authors: B
authors: Marescau
authors: P
authors: P
authors: De Deyn
authors: D
authors: D
authors: Stout
authors: L
authors: L
authors: Schlichting
authors: W W
authors: WW
authors: Grody
authors: S D
authors: SD
authors: Cederbaum
authors: G S
authors: GS
authors: Lipshutz
mesh_terms: D000818:Animals; D001119:Arginase / Q000235:genetics* / Q000378:metabolism; D000229:Dependovirus; D004195:Disease Models, Animal; D015316:Genetic Therapy; D006801:Humans; D022124:Hyperammonemia / Q000235:genetics / Q000473:pathology / Q000628:therapy; D020162:Hyperargininemia / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D051379:Mice; D008822:Mice, Transgenic; D009422:Nervous System Diseases / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D019636:Neurodegenerative Diseases / Q000235:genetics* / Q000473:pathology / Q000628:therapy
chemical_list: C574619:ARG1 protein, human; D001119:Arginase
references: Mamm Genome. 2000 Sep;11(9):725-8
references: 10967129
references: Nat Protoc. 2006;1(2):848-58
references: 17406317
references: Nat Protoc. 2007;2(2):322-8
references: 17406592
references: Gene Ther. 2012 Dec;19(12):1166-76
references: 22241178
references: Pharmacol Biochem Behav. 1996 May;54(1):21-30
references: 8728535
references: Int J Dev Neurosci. 2003 Apr;21(2):75-82
references: 12615083
references: Mol Imaging Biol. 2005 Nov-Dec;7(6):393-402
references: 16261425
references: J Genet Hum. 1976 Mar;24(1):61-72
references: 819629
references: Nat Genet. 1995 Oct;11(2):185-90
references: 7550347
references: Mol Genet Metab. 2010;100 Suppl 1:S31-6
references: 20176499
references: Epilepsy Res. 1991 Mar;8(2):134-41
references: 1712285
references: Psychopharmacologia. 1968 Sep 20;13(3):222-57
references: 5679627
references: Brain Res. 1988 May 24;449(1-2):54-60
references: 3395858
references: Cancer Res. 2000 Jun 15;60(12):3305-12
references: 10866325
references: Pediatr Res. 1997 Apr;41(4 Pt 1):527-34
references: 9098855
references: Mol Cell Biol. 2002 Jul;22(13):4491-8
references: 12052859
references: News Physiol Sci. 1998 Jun;13:118-123
references: 11390774
references: Mol Ther. 2012 Oct;20(10):1844-51
references: 22760543
references: Metabolism. 1992 Sep;41(9):1021-4
references: 1518417
references: Mol Genet Metab. 2011 Sep-Oct;104(1-2):107-11
references: 21802329
references: Comp Med. 2005 Aug;55(4):310-6
references: 16158906
references: J Genet Hum. 1972 Mar;20(1):69-84
references: 4643877
references: J Inherit Metab Dis. 1998;21 Suppl 1:86-100
references: 9686347
references: Metabolism. 1997 Sep;46(9):1024-31
references: 9284891
references: J Child Neurol. 1997 Aug;12(5):301-9
references: 9378897
references: J Gene Med. 2010 Sep;12(9):766-78
references: 20821747
references: Tohoku J Exp Med. 1987 Nov;153(3):197-205
references: 3433275
references: Clin Chim Acta. 1985 Feb 28;146(1):21-7
references: 3987036
references: Pediatr Res. 1990 Mar;27(3):297-303
references: 1690873
references: Mamm Genome. 1997 Oct;8(10):711-3
references: 9321461
references: Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R315-26
references: 16601258
references: Comp Biochem Physiol B Biochem Mol Biol. 1996 May;114(1):107-32
references: 8759304
references: J Pediatr. 2003 Mar;142(3):349-52
references: 12640389
references: Clin Chem. 1971 May;17(5):400-2
references: 5573405